RxDoctor Payments Data

Leslie Kipp

Family · Bedford, TXNPI 1144722539

Payments from drug & device makers

$2,595in general payments, 2019–2025

Across 144 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$377
  • Teva Pharmaceuticals USA, Inc.$296
  • Novo Nordisk$173
  • Lilly USA, LLC$164
  • Amgen$139
  • Bayer$129
  • plus $1K from 34 others

What the payments were for

  • Food & beverage$2,595100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,595 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin56$30,658
OzempicSemaglutide21$26,662
TrulicityDulaglutide23$21,171
JanuviaSitagliptin Phosphate36$11,888
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$7,560
Potassium Chloride47$6,719
Lacosamide15$4,281
Ondansetron Hcl23$1,875
Sodium Chloride0.9 % Sodium Chloride24$1,797
Tramadol Hcl49$1,212
Levothyroxine Sodium102$1,154
Omeprazole58$1,137
Gabapentin74$1,044
Hydralazine Hcl44$948
Memantine Hcl19$938

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$83$30,65856 claims
Novo NordiskOzempic$173$26,66221 claims
Lilly USA, LLCTrulicity$164$21,17123 claims
MerckJanuvia$38$11,88836 claims
GSKTrelegy Ellipta$34$7,56012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 15,456 family providers in Texas.

Other family in Bedford

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →